Based on experience and the existing limited research literature in biotechnology corporate governance, the authors propose potential attributes of minimum corporate governance standards for biotechnology companies, as a basis for further quantitative and qualitative research. The authors assert that the recent proliferation of biotechnology start-up organisations is substantively changing inter- and intra-organizational cultures throughout the healthcare sector via a ‘cascade of governance’.
Therefore, governance decisions and actions – both positive and negative – that are instituted in start-up biotech companies may set new norms for other start-up biotech companies, the larger (bio)pharmaceutical companies by which they are acquired and the range of healthcare sub-sector actors that interact with biotechnology companies.
TF-1 |
|||
| MBS201021-5x05mg | MyBiosource | 5x0.5mg | EUR 1115 |
TF-1 Cell Line |
|||
| CL-0232 | Elabscience Biotech | 1×10⁶ cells/vial | EUR 420 |
|
Description: Homo sapiens, Human |
|||
TF (untagged)-Human transferrin (TF) |
|||
| SC322130 | Origene Technologies GmbH | 10 µg | Ask for price |
TF (GFP-tagged) - Human transferrin (TF) |
|||
| RG209184 | Origene Technologies GmbH | 10 µg | Ask for price |
TF-1 Cells Complete Medium |
|||
| CM-0232-125mL4 | Elabscience Biotech | 125 mL×4 | EUR 158 |
|
Description: Complete Growth Medium |
|||
TF-1 Cells Complete Medium |
|||
| CM-0232 | Elabscience Biotech | 125mL×4 | EUR 158 |
|
Description: Cell lines complete growth medium |
|||
TF-1 Cells Complete Medium |
|||
| MBS2568732-4x125mL | MyBiosource | 4x125mL | EUR 195 |
TF antibody |
|||
| 10R-6059 | Fitzgerald | 100 ul | EUR 709 |
|
Description: Mouse monoclonal TF antibody |
|||
TF Antibody |
|||
| 36753 | SAB | 100ul | EUR 319 |
TF Antibody |
|||
| 36753-100ul | SAB | 100ul | EUR 302.4 |
TF Antibody |
|||
| E036753 | EnoGene | 100μg/100μl | EUR 255 |
|
Description: Available in various conjugation types. |
|||
TF Antibody |
|||
| 1-CSB-PA917773 | Cusabio |
|
|
|
Description: A polyclonal antibody against TF. Recognizes TF from Human. This antibody is Unconjugated. Tested in the following application: ELISA, WB, IHC;ELISA:1:1000-1:2000, WB:1:500-1:2000, IHC:1:25-1:100 |
|||
TF Antibody |
|||
| 1-CSB-PA023412GA01HU | Cusabio |
|
|
|
Description: A polyclonal antibody against TF. Recognizes TF from Human, Mouse, Rat. This antibody is Unconjugated. Tested in the following application: ELISA, WB, IHC |
|||
Serotransferrin/Tf |
|||
| E21-J41 | EnoGene | 10ug | EUR 225 |
|
Description: Recombinant Human Transferrin is produced by our Mammalian expression system and the target gene encoding Val20-Pro698 is expressed with a 6His tag at the C-terminus. |
|||
TF Antibody |
|||
| E92832 | EnoGene | 100μg | EUR 255 |
|
Description: Available in various conjugation types. |
|||
TF Antibody |
|||
| E314380 | EnoGene | 100ug/200ul | EUR 295 |
|
Description: Available in various conjugation types. |
|||
TF siRNA |
|||
| 20-abx905542 | Abbexa |
|
|
TF Antibody |
|||
| CAC07413-100ug | Biomatik Corporation | 100ug | EUR 314 |
TF Antibody |
|||
| CAC07413-50ug | Biomatik Corporation | 50ug | EUR 199.2 |
Tf Antibody |
|||
| CAC10356-100ug | Biomatik Corporation | 100ug | EUR 314 |
Tf Antibody |
|||
| CAC10356-50ug | Biomatik Corporation | 50ug | EUR 199.2 |
TF antibody |
|||
| 70R-20775 | Fitzgerald | 50 ul | EUR 289 |
|
Description: Rabbit polyclonal TF antibody |
|||
TF siRNA |
|||
| 20-abx936606 | Abbexa |
|
|
TF siRNA |
|||
| 20-abx936607 | Abbexa |
|
|
Tf Antibody |
|||
| 1-CSB-PA00470E0Rb | Cusabio |
|
|
|
Description: A polyclonal antibody against Tf. Recognizes Tf from Rat. This antibody is Unconjugated. Tested in the following application: ELISA, WB; Recommended dilution: WB:1:1000-1:5000 |
|||
TF Antibody |
|||
| 1-CSB-PA005189 | Cusabio |
|
|
|
Description: A polyclonal antibody against TF. Recognizes TF from Human, Mouse, Rat. This antibody is Unconjugated. Tested in the following application: WB, ELISA;WB:1/500-1/2000.ELISA:1/20000 |
|||
TF Antibody |
|||
| 1-CSB-PA080189 | Cusabio |
|
|
|
Description: A polyclonal antibody against TF. Recognizes TF from Human, Mouse, Rat. This antibody is Unconjugated. Tested in the following application: WB, IHC;WB:1:5000-10000.IHC:1:200-500 |
|||
TF Antibody |
|||
| 1-CSB-PA553268 | Cusabio |
|
|
|
Description: A polyclonal antibody against TF. Recognizes TF from Human. This antibody is Unconjugated. Tested in the following application: ELISA, WB;ELISA:1:2000-1:5000, WB:1:500-1:2000 |
|||
TF Antibody |
|||
| 1-CSB-PA00250E0Rb | Cusabio |
|
|
|
Description: A polyclonal antibody against TF. Recognizes TF from Human. This antibody is Unconjugated. Tested in the following application: ELISA, WB; Recommended dilution: WB:1:1000-1:5000 |
|||
TF | Transferrin |
|||
| IMS02-020-322 | Agrisera AB | 100 µl (1 µg/µl) | EUR 348 |
TF Antibody |
|||
| GWB-48BAC0 | GenWay Biotech | 0.1 ml | Ask for price |
TF Antibody |
|||
| GWB-MW727G | GenWay Biotech | 50ug | Ask for price |
TF-505 |
|||
| T28956-10mg | TargetMol Chemicals | 10mg | Ask for price |
|
Description: TF-505 |
|||
TF-505 |
|||
| T28956-1g | TargetMol Chemicals | 1g | Ask for price |
|
Description: TF-505 |
|||
TF-505 |
|||
| T28956-1mg | TargetMol Chemicals | 1mg | Ask for price |
|
Description: TF-505 |
|||
TF-505 |
|||
| T28956-50mg | TargetMol Chemicals | 50mg | Ask for price |
|
Description: TF-505 |
|||
TF-505 |
|||
| T28956-5mg | TargetMol Chemicals | 5mg | Ask for price |
|
Description: TF-505 |
|||
TF Antibody |
|||
| K16184M02D04C-100ug | Absea Biotechnology | 100 ug | EUR 320 |
|
Description: Monoclonal Antibody |
|||
TF Antibody |
|||
| K16184M02D04C-1mg | Absea Biotechnology | 1 mg | EUR 1600 |
|
Description: Monoclonal Antibody |
|||
TF Antibody |
|||
| K16184M02D04C-50ug | Absea Biotechnology | 50 ug | EUR 224 |
|
Description: Monoclonal Antibody |
|||
TF Antibody |
|||
| K16184M07A07C-100ug | Absea Biotechnology | 100 ug | EUR 320 |
|
Description: Monoclonal Antibody |
|||
TF Antibody |
|||
| K16184M07A07C-1mg | Absea Biotechnology | 1 mg | EUR 1600 |
|
Description: Monoclonal Antibody |
|||
TF Antibody |
|||
| K16184M07A07C-50ug | Absea Biotechnology | 50 ug | EUR 224 |
|
Description: Monoclonal Antibody |
|||
TF Antibody |
|||
| K16184M13F07C-100ug | Absea Biotechnology | 100 ug | EUR 320 |
|
Description: Monoclonal Antibody |
|||
TF Antibody |
|||
| K16184M13F07C-1mg | Absea Biotechnology | 1 mg | EUR 1600 |
|
Description: Monoclonal Antibody |
|||
TF Antibody |
|||
| K16184M13F07C-50ug | Absea Biotechnology | 50 ug | EUR 224 |
|
Description: Monoclonal Antibody |
|||
TF-505 |
|||
| MBS5778622-5mg | MyBiosource | 5(mg | EUR 915 |
TF-505 |
|||
| MBS5778622-5x5mg | MyBiosource | 5x5(mg | EUR 3970 |
Tf Antibody |
|||
| MBS7134854-005mL | MyBiosource | 0.05mL | EUR 190 |
Tf Antibody |
|||
| MBS7134854-01mL | MyBiosource | 0.1mL | EUR 270 |
Tf Antibody |
|||
| MBS7134854-5x01mL | MyBiosource | 5x0.1mL | EUR 1205 |
TF Antibody |
|||
| MBS7126858-005mL | MyBiosource | 0.05mL | EUR 190 |
TF Antibody |
|||
| MBS7126858-01mL | MyBiosource | 0.1mL | EUR 270 |
TF Antibody |
|||
| MBS7126858-5x01mL | MyBiosource | 5x0.1mL | EUR 1205 |
TF Antibody |
|||
| MBS7126859-005mL | MyBiosource | 0.05mL | EUR 190 |
TF Antibody |
|||
| MBS7126859-01mL | MyBiosource | 0.1mL | EUR 270 |
TF Antibody |
|||
| MBS7126859-5x01mL | MyBiosource | 5x0.1mL | EUR 1205 |
TF Antibody |
|||
| MBS7122396-005mg | MyBiosource | 0.05mg | EUR 150 |
TF Antibody |
|||
| MBS7122396-01mg | MyBiosource | 0.1mg | EUR 190 |
TF Antibody |
|||
| MBS7122396-5x01mg | MyBiosource | 5x0.1mg | EUR 845 |
TF Antibody |
|||
| MBS7122546-005mg | MyBiosource | 0.05mg | EUR 150 |
TF Antibody |
|||
| MBS7122546-01mg | MyBiosource | 0.1mg | EUR 190 |
TF Antibody |
|||
| MBS7122546-5x01mg | MyBiosource | 5x0.1mg | EUR 845 |
TF Antibody |
|||
| MBS9404844-01mL | MyBiosource | 0.1mL | EUR 305 |
TF Antibody |
|||
| MBS9404844-5x01mL | MyBiosource | 5x0.1mL | EUR 1230 |
TF Antibody |
|||
| MBS8505399-01mg | MyBiosource | 0.1mg | EUR 325 |
TF Antibody |
|||
| MBS8505399-01mLAF405L | MyBiosource | 0.1mL(AF405L) | EUR 565 |
TF Antibody |
|||
| MBS8505399-01mLAF405S | MyBiosource | 0.1mL(AF405S) | EUR 565 |
TF Antibody |
|||
| MBS8505399-01mLAF610 | MyBiosource | 0.1mL(AF610) | EUR 565 |
TF Antibody |
|||
| MBS8505399-01mLAF635 | MyBiosource | 0.1mL(AF635) | EUR 565 |
TF antibody |
|||
| MBS838584-01mL | MyBiosource | 0.1mL | EUR 1095 |
TF antibody |
|||
| MBS838584-5x01mL | MyBiosource | 5x0.1mL | EUR 4770 |
Serotransferrin/Tf |
|||
| MBS8532988-001mg | MyBiosource | 0.01mg | EUR 305 |
Serotransferrin/Tf |
|||
| MBS8532988-5x001mg | MyBiosource | 5x0.01mg | EUR 1220 |
TF Antibody |
|||
| MBS9507489-005mL | MyBiosource | 0.05mL | EUR 285 |
TF Antibody |
|||
| MBS9507489-01mL | MyBiosource | 0.1mL | EUR 385 |
TF Antibody |
|||
| MBS9507489-5x01mL | MyBiosource | 5x0.1mL | EUR 1590 |
AAVS1-TF |
|||
| PVTY00185 | Nova Lifetech | 2ug | EUR 280 |
pCold TF |
|||
| PVTY00752 | Nova Lifetech | 2ug | EUR 280 |
pCold TF |
|||
| PVT0605 | Nova Lifetech | 2ug | EUR 216 |
pCold TF |
|||
| PVT10602 | Nova Lifetech | 2ug | EUR 215 |
pBluescriptR-TF |
|||
| PVT21806 | Nova Lifetech | 2ug | EUR 280 |
TF Antibody |
|||
| B0873-100ul | Assay Biotech | 100μl | EUR 217 |
|
Description: TF Rabbit Polyclonal Antibody |
|||
TF Antibody |
|||
| B0873-50ul | Assay Biotech | 50μl | EUR 143.5 |
|
Description: TF Rabbit Polyclonal Antibody |
|||
TF Antibody |
|||
| C30125-100ul | Assay Biotech | 100μl | EUR 217 |
|
Description: TF Rabbit Polyclonal Antibody |
|||
TF Antibody |
|||
| C30125-50ul | Assay Biotech | 50μl | EUR 143.5 |
|
Description: TF Rabbit Polyclonal Antibody |
|||
TF Antibody |
|||
| C47549-100ul | Assay Biotech | 100μl | EUR 217 |
|
Description: TF Rabbit Polyclonal Antibody |
|||
TF Antibody |
|||
| C47549-50ul | Assay Biotech | 50μl | EUR 143.5 |
|
Description: TF Rabbit Polyclonal Antibody |
|||
TF (Myc-DDK-tagged)-Human transferrin (TF) |
|||
| RC209184 | Origene Technologies GmbH | 10 µg | Ask for price |
Anti-TF Antigen Peptide P30-1 |
|||
| H-5988.0001 | Bachem | 1.0mg | EUR 283.2 |
|
Description: Sum Formula: C94H130N26O19; CAS# [573664-50-3] net |
|||
Anti-TF Antigen Peptide P30-1 |
|||
| H-5988.0005 | Bachem | 5.0mg | EUR 1023.6 |
|
Description: Sum Formula: C94H130N26O19; CAS# [573664-50-3] net |
|||
Tf (untagged ORF) - Rat transferrin (Tf), (10 ug) |
|||
| RN204940 | Origene Technologies GmbH | 10 µg | Ask for price |
Transferrin (TF) Antibody |
|||
| 20-abx110281 | Abbexa |
|
|
Transferrin (TF) Antibody |
|||
| 20-abx110658 | Abbexa |
|
|
Transferrin (TF) Antibody |
|||
| 20-abx110659 | Abbexa |
|
|
Transferrin (TF) Antibody |
|||
| 20-abx104833 | Abbexa |
|
|
Transferrin (TF) Antibody |
|||
| 20-abx100678 | Abbexa |
|
|
Transferrin (TF) Antibody |
|||
| 20-abx100679 | Abbexa |
|
|
Transferrin (TF) Antibody |
|||
| 20-abx100680 | Abbexa |
|
|
Transferrin (TF) Antibody |
|||
| 20-abx100681 | Abbexa |
|
|
Transferrin (TF) Antibody |
|||
| 20-abx100682 | Abbexa |
|
|
Transferrin (TF) Antibody |
|||
| 20-abx100683 | Abbexa |
|
|
Transferrin (TF) Antibody |
|||
| 20-abx100684 | Abbexa |
|
|
Transferrin (TF) Antibody |
|||
| 20-abx100685 | Abbexa |
|
|
Transferrin (TF) Antibody |
|||
| 20-abx100686 | Abbexa |
|
|
Transferrin (TF) Antibody |
|||
| 20-abx100687 | Abbexa |
|
|
TF Recombinant Protein |
|||
| 91-434 | ProSci | 0.05 mg | EUR 821.4 |
|
Description: Tissue Factor (TF) is a single-pass type I membrane glycoprotein member of the tissue factor family. TF expression is highly dependent upon cell type. This factor enables cells to initiate the blood coagulation cascades, and it functions as the high-affinity receptor for the coagulation factor VII. TF initiates blood coagulation by forming a complex with circulating factor VII or VIIa. The complex activates factors IX or X by specific limited protolysis. TF plays a role in normal hemostasis by initiating the cell-surface assembly and propagation of the coagulation protease cascade. |
|||
Transferrin (TF) Antibody |
|||
| 20-abx128601 | Abbexa |
|
|
Transferrin (TF) Antibody |
|||
| 20-abx129951 | Abbexa |
|
|
Transferrin (TF) Antibody |
|||
| abx139902-01mg | Abbexa | 0.1 mg | EUR 427.2 |
The authors stress the importance of appropriate, proportionate and consistent biotech corporate governance throughout company lifecycles, not simply to support value inflection or as a response to a crisis. Fail to govern, fail to succeed – for investors and, most importantly, for patients.
